A detailed history of Parallel Advisors, LLC transactions in Schrodinger, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 63 shares of SDGR stock, worth $1,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63
Previous 40 57.5%
Holding current value
$1,224
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$18.05 - $24.02 $415 - $552
23 Added 57.5%
63 $1,000
Q2 2024

Aug 08, 2024

SELL
$18.65 - $28.5 $1,007 - $1,539
-54 Reduced 57.45%
40 $0
Q1 2024

May 06, 2024

BUY
$24.74 - $35.13 $1,187 - $1,686
48 Added 104.35%
94 $2,000
Q4 2023

Feb 09, 2024

BUY
$21.62 - $37.21 $129 - $223
6 Added 15.0%
46 $1,000
Q3 2023

May 20, 2024

SELL
$27.34 - $55.37 $1,476 - $2,989
-54 Reduced 57.45%
40 $1,000
Q3 2023

Nov 13, 2023

BUY
$27.34 - $55.37 $1,093 - $2,214
40 New
40 $1,000
Q3 2022

Nov 10, 2022

BUY
$23.95 - $34.71 $239 - $347
10 New
10 $0
Q2 2022

Aug 01, 2022

SELL
$21.39 - $35.9 $171 - $287
-8 Closed
0 $0
Q1 2022

Apr 28, 2022

SELL
$24.84 - $36.12 $496 - $722
-20 Reduced 71.43%
8 $0
Q4 2021

Jan 20, 2022

SELL
$33.38 - $59.25 $1,936 - $3,436
-58 Reduced 67.44%
28 $1,000
Q3 2021

Nov 02, 2021

BUY
$53.75 - $76.55 $4,031 - $5,741
75 Added 681.82%
86 $5,000
Q2 2021

Aug 06, 2021

BUY
$59.02 - $78.8 $295 - $394
5 Added 83.33%
11 $1,000
Q4 2020

Feb 02, 2021

BUY
$48.06 - $84.4 $288 - $506
6 New
6 $0
Q3 2020

Oct 27, 2020

SELL
$46.87 - $93.33 $2,343 - $4,666
-50 Closed
0 $0
Q2 2020

Jul 16, 2020

BUY
$36.12 - $91.57 $1,805 - $4,578
50 New
50 $4,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.21B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.